KIRSKE DAVID (Chief Financial Officer) sold 4.8% of their position (8.54K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $36.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0001501697-26-000065
Officer· Chief Financial Officer
Since Aug 2025
-8.54K
Net shares
Net seller
$36.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.54K
Price / share
$4.26
Trade value
$36.43K
% of position
4.8%
6/30/2026
176.29K→167.75K
Total
Net shares
−8.54K
Net value
-$36.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | S · Sale | −8.54K | $4.26 | $36.43K | 4.8% | 176.29K | 167.75K |
| Total | −8.54K | -$36.43K | ||||||
Derivative Transactions0
No derivative transactions reported